New Research Reports for Pfizer, Cisco & Visa

Loading...
Loading...

Monday, August 22, 2016

Today's Research Daily write-up features fresh analyst reports on 16 major companies, including Pfizer PFE, Cisco CSCO and Visa V. These 16 reports have been handpicked from the roughly 80 research reports issued by the Zacks analysts team today. You can see the complete list of today's research reports here >>>

Pfizer is dominating the headlines today, with its $14 billion purchase of cancer drug maker Medivation MDVN that is expecetd to be accretive to the drug giant's earnings in the first year. Synergies aside, this deal in totally inline with Pfizer's efforts to strengthen its product portfolio as well as its pipeline through acquisitions and licensing deals. Meanwhile, new products like Ibrance should drive revenues while cost-savings and share buybacks should help the drugmaker achieve its earnings guidance. (You can read the full research report on Pfizer here>>)

Cisco shares performed strongly this year, up 12% year-to-date, with market participants getting comfortable with the networking giant's growth plans. The company's quarterly report was mixed - it beat June quarter estimates, but the outlook was on the weak side. In today's research report, the Zacks analyst discusses the pros & cons of investing in Cisco shares at present. The analyst refers to Cisco's cloud computing challenge, but likes the company's market position, innovative prowess, product range and growth initiatives.The recent acquisition of CloudLock will help Cisco to broaden its efforts and meet changing compliance and security needs. (You can read the full research report on Cisco here>>)

Loading...
Loading...

Visa shares have lagged the broader market lately, as have rival MasterCard's, on concerns about the network's long-term growth outlook in the face of growing competition from new payment platforms. These issues notwithstanding, the analyst likes the company's acquisition of Visa Europe, since it is likely to open vast business opportunities in the region and provide it with greater scale and diversification. Its other strategic acquisitions and alliances, technology upgrades and effective marketing efforts bode well for long-term growth. (You can read the full research report on Visa here>>)

Other noteworthy reports we are featuring today include McDonald's MCD, Raytheon RTN and Vertex VRTX.

Today's Long-Term Buys & Sells
Today you can gain access to the best long-term trades unearthed by Zacks Research. These moves have double and triple-digit profit potential and are rarely available to the public. Starting now, you can look inside our stocks under $10, home run and value stock portfolios, plus more. Want a peek at this private information? Click here >>

You can find all of today's stock research reports here >>>

Sheraz Mian

Director of Research

Featured Reports

McDonald's MCD Tops Q2 Earnings, Lags Revenues

The Zacks analyst believes that the turnaround plan announced by CEO Steve Easterbrook in May 2015 aided McDonald's to beat on Q2 earnings.

Sysco SYY Tops Q4 Earnings on Improved Margins

The Zacks analyst thinks focus on acquisition and margin improvement probably resulted in the beat.

Kellogg K Beats Q2 Earnings; Cuts 2016 Sales View

The Zacks analyst believes Kellogg delivered better-than-expected Q2 earnings on the back of robust cost savings. However, sales fell short of expectations amid cereal/snacks category challenges.

Public Service's PEG Q2 Earnings In Line with Estimates

The Zacks analyst believes that its solid portfolio of regulated and non-regulated utility assets offer notable long-term growth potential.

Eni's E Q2 Loss Wider than Expected, Cashflow Remains Strong

Eni plans to undergo an alteration to boost growth as well as meet short-term financial constraints. However, the Zacks Analyst believes Eni continues to struggle against uncertainty in the Euro Zone.

Raytheon RTN Beats on Q2 Earnings, Boosts EPS Outlook

Raytheon raised its 2016 guidance for margins, operating cash flow and EPS. The Zacks analyst believes international sales continue to be the vital growth driver for Raytheon.

Vertex VRTX Posts Narrower Q2 Loss, Revenues Fall Short

The Zacks analyst thinks Vertex is well-positioned for growth with both its marketed drugs representing blockbuster potential.

New Upgrades

L Brands LB Beats on Q2 Earnings, Raises Outlook

Sustained focus on cost control, inventory management, merchandise and speed-to-market initiatives helped the company post solid results and provide an encouraging outlook, per the Zacks analyst.

Ross Stores ROST Tops Q2 Earnings & Sales, Ups FY16 View

The covering analyst thinks Ross Stores is gaining from robust second-quarter performance and raised earnings projections for the fiscal.

NetApp's NTAP Strategic Endeavors to Propel Growth

The Zacks analyst believes that NetApp's recent product launches and acquisition will drive its top line, while cost reduction initiatives will facilitate margin expansion.

New Downgrades

Infineon's (IFNNY) Prospects Hurt as Smartphone Sales Dip

Currency volatility and persistent weakness in the global smartphone market are posing major concerns for Infineon. Also, strong competition and cyclical nature of the industry are hurting margins.

Global Uncertainty, Generic Threats to Hit Bayer (BAYRY)

The Zacks analyst believes that weak macroeconomic conditions and generic competition are likely to affect Bayer's performance. Moreover, pipeline setbacks could affect the company adversely.

Sohu's SOHU Troubles Increase, Turnaround Elusive

Sohu's search and mobile business is growing, its brand advertising business remains sluggish. Increasing investments are proving to be a drag on margins observes the Zacks analyst.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report

VISA INC-A V: Free Stock Analysis Report

PFIZER INC PFE: Free Stock Analysis Report

MEDIVATION INC MDVN: Free Stock Analysis Report

MCDONALDS CORP MCD: Free Stock Analysis Report

CISCO SYSTEMS CSCO: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Loading...
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...